Report Overview

Real-time PCR (qPCR) Assay Market Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global real-time PCR (qPCR) assay market was valued at US$ 4.10 billion in 2021 and is expected to register a revenue CAGR of 7.4% to reach USD 7.24 billion by 2030.

Real-time PCR (qPCR) Assay Market Fundamentals

Polymerase chain reaction (PCR) utilizes polymerase enzymes, primers, and multiple thermal cycles to generate an infinite number of copies of DNA from a single strand. As PCR diagnostics are performed in automated thermal cyclers, they are less susceptible to cross-contamination. Real-time PCR (qPCR) is a common diagnostic technique used in research in pharmaceutical and biotech institutes, and it finds extensive application in a wide range of life sciences applications.

Real-time PCR enables specific and early disease diagnosis, allowing patients to receive the appropriate response and targeted treatment at a quick turnaround time. Additionally, PCR techniques are more specific than traditional infectious disease detection methods, such as immunoassays, and have become an integral part of diagnostic laboratories, facilitating market revenue growth.

[898765]

Real-time PCR (qPCR) Assay Market Dynamics

Rise in the incidence of infectious diseases and genetic disorders and increase in the number of diagnostic centers and hospitals are expected to drive revenue growth in the real-time PCR (qPCR) assay market. Genomic analysis tools are being increasingly utilized in the recent few years in the diagnosis of major infectious diseases (such as HIV, tuberculosis, malaria, and hepatitis) and genetic abnormalities (such as cancer). Rise in the prevalence of targeted disease, combined with the demonstrated efficacy of qPCR analysis in the diagnosis and estimation of disease-causing microorganisms, is expected to drive the adoption of clinical diagnostic tests. This, in turn, is likely to fuel revenue growth in the global market.

However, high costs associated with instruments and increase in need for capital investments on larger scales to develop advanced devices are expected to hinder revenue growth in the market in the next few years. 

Real-time PCR (qPCR) Assay Market Ecosystem

The global real-time PCR (qPCR) assay market is segmented based on four parameters: product, application, end user, and region.

Real-time PCR (qPCR) Assay Market by Product Type

[5746534343]

Based on the product type, the global real-time PCR (qPCR) assay market is segmented into reagents & consumables and instruments.

The reagents & consumables segment dominates the market, due to the emergence of the COVID-19 pandemic, increased demand for early disease detection, and rise in the number of companies producing qPCR consumables and reagents. Furthermore, the widespread usage of consumables and reagents and growing demand for healthcare and research activities is expected to contribute to the segment’s significant revenue share. Moreover, rising prevalence of chronic diseases and increasing usage of qPCR have resulted in a rise in the demand for consumables and reagents. Besides this, increasing acceptance of technological innovations by the pharmaceutical and healthcare industries and rise in R&D activities are likely to generate significant business opportunities in the segment during the forecast period.

Template cDNA, upstream and downstream primers, GoTaq DNA polymerase with reaction buffer, dNTP mixture, molecular grade, nuclease-free water, and agarose are the various reagents and assays used for real-time PCR. Furthermore, real-time PCR consumables include plastics and supplies for qPCR experiments, such as tubes, plates, caps, adhesive plate seals, strips, and racks. They are supported for optimal performance with real-time PCR systems. 

Real-time PCR (qPCR) Assay Market by Application

Based on the application, the global real-time PCR (qPCR) assay market is segmented into clinical research and forensics.

The clinical segment accounts for the largest revenue share, due to rising prevalence of cancer, diabetes, and infectious diseases, high precision of testing methods, increasing commercialization of diagnostic reagents, efficient disease diagnosis, monitoring, and treatment, and additional benefits in disease detection. However, the forensic segment is likely to register the fastest revenue growth during the forecast period. The segment is expected to be driven by increasing usage of novel techniques in forensic applications, such as DNA typing, genetic fingerprinting, and DNA testing.

Real-time PCR (qPCR) Assay Market by End User

Based on the end user, the global real-time PCR (qPCR) assay market is segmented into hospitals & diagnostic centers, academic & research institutes, pharmaceutical & biotechnology industries, and others.

The hospitals and diagnostic centers segment accounts for the largest revenue share of the market. This can be attributed to the growing demand for early and efficient disease diagnosis and treatment, increasing number of qPCR product launches for diagnostic applications, benefits of qPCR in disease diagnosis (when compared to other PCR technologies), and growing public awareness about the advantages of qPCR in disease diagnosis.

Real-time PCR (qPCR) Assay Market by Region

Based on the region, the global real-time PCR (qPCR) assay market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

North America is expected to register the highest revenue growth during the forecast period. This can be ascribed to increasing adoption of advanced and original genomic analysis products, such as innovative Real-time PCR (qPCR) products. Increased availability of R&D funding for genomic research, combined with the region's robust research infrastructure, is driving the revenue growth of the real-time PCR (qPCR) assay market in North America. When compared to other regions, North America is registering rapid revenue growth due to the early commercialization of several real-time PCR (qPCR) products.

Real-time PCR (qPCR) Assay Market Competitive Landscape

Leading players operating in the global real-time PCR (qPCR) assay market include: -

• Thermo Fisher Scientific Inc
• Bio-Rad Laboratories Inc
• Abbott Laboratories Inc
• F. Hoffmann-La Roche, Ltd
• Becton Dickinson and Company
• Analytik Jena AG
• Agilent Technologies Inc
• Eppendorf AG
• Fluidigm Corporation
• Merck KGaA
• Takara Bio
• Qiagen N.V. 

Real-time PCR (qPCR) Assay Market Strategic Developments

• In December 2021, Bio-Rad acquired Dropworks for $ 125 million. Dropworks was developing a droplet-based digital PCR system that intended to provide a more cost-effective solution for improving PCR workflow and assisting Bio-Rad in entering the lower-end segment for their ddPCR platforms. Bio-Rad can continue to make similar deals and ensure future revenue growth by utilizing its cash position.
• In March 2020, Abbott Laboratories launched the m2000 RealTime SARS-CoV-2 EUA test, which also runs on the m2000 RealTime System, found in hospitals and reference labs around the world. The company intends to produce approximately 5 million tests per month.

Frequently Asked Questions About This Report